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Abstract 
Ovarian teratomas are occasionally reported in dogs; the rarest type is the monophasic teratoma, 
composed of tissues originating from only one germ layer. Canine endometrial adenocarcinomas are 
also rare in dogs and mainly affect geriatric females.  
This report describes case of co-existing ovarian teratoma and uterine adenocarcinoma in a 10-year-
old nulliparous female Boxer presented with lethargy, anorexia and purulent vaginal discharge. 
Abdominal ultrasonography evidenced pyometra and a mass in the left ovary. This was composed of 
a uniform whitish tissue with multiple cystic structures. The histology revealed an atrophy of the 
ovarian parenchyma, compressed by a proliferation of well-differentiated nervous tissue staining 
positively to vimentin, S100 and neuronal specific enolase (NSE), and negatively to keratin and 
inhibin. The left uterine horn, whose diameter was markedly increased, showed foci of endometrial 
cellular atypia, evident nucleoli and mitoses, at light microscopy.  
To our best knowledge, this is the first report of a coexisting ovarian monophasic teratoma and 
endometrial adenocarcinoma, two rare reproductive neoplasia in dogs. 
 
Keywords: Monophasic teratoma, endometrial adenocarcinoma, dog 
 
Introduction 
Primary ovarian neoplasms account for 6.25% of the neoplasms in intact bitches, but only 0.45-1.2% 
of all canine neoplasms (Pires et al. 2003; Saba and Lawrence 2017). Teratomas are the rarest 
ovarian tumors (2 to 10% of all ovary tumors) in dogs, and affect mainly adult and geriatric patients 
(Rota et al. 2013). Arising from totipotent germ cells, they are characteristically composed of tissue 
derived from any of the three different embryonic germ layers (Nagashima et al. 2000). When only 
one germ layer component is present, they are classified as monophasic (Rota et al. 2013).  
In general, well-differentiated teratomas display a benign biological behavior, remaining unnoticed 
through large periods of time. Conversely, malignant variants (teratocarcinomas) present 
proliferation of poorly differentiated cells from multiple origins, with high metastatic potential (rates 
of 30-50%). Metastases have been reported in the peritoneum, kidney, abdominal lymph nodes, 
lungs, adrenal glands and bones (Saba and Lawrence 2012). Initially, teratomas evolve silently, but 
show clinical signs after a given size or in malignant conditions, such as a palpable abdominal mass, 
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abdominal discomfort, fever, apathy, lameness, vomiting, weight loss and anorexia (Greenlee and 
Patnaik 1985). 
Uterine tumors are also uncommon in dogs (prevalence of 0.3-0.4%), affecting mainly middle-aged 
to geriatric females. They can be classified as epithelial or mesenchymal in origin. Epithelial tumors 
may be separated in adenoma and adenocarcinoma, which are the rarest type (Pires et al. 2010). 
Leiomyoma is the most common uterine tumor, comprising 85-90% of the cases described (Saba and 
Lawrence 2012). The clinical signs of uterine adenocarcinoma resemble those of other uterine 
diseases, namely purulent or hemorrhagic vaginal discharge, dysuria/hematuria, anorexia, 
abdominal pain, abdominal distension and anorexia (Pires et al. 2010). 
Albeit ovarian and uterine masses may be identified using imaging diagnostic, but only 
histopathology provides a conclusive diagnosis (Coggeshall et al, 2012). Ovariohysterectomy is 
recommended as treatment in most cases and is curative if no metastatic disease is present (Saba 
and Lawrence, 2012).  
This report describes two rare reproductive neoplasms coexisting in a Boxer female dog. To our best 
knowledge, this is the first report of concomitant ovarian monophasic teratoma and uterine 
adenocarcinoma described in the dog. 
 
Case Report 
A 10-year-old nulliparous female Boxer was admitted to the University Veterinary Hospital of 
Coimbra due to lethargy, anorexia and purulent vaginal discharge. Anamnesis highlighted existing 
regular estrous cycles at six months intervals, and inexistence of contraceptive treatments. Last 
estrus was recorded 5 months ago. The clinical and gynecologic examinations were completed with 
hematology [showed mild neutrophilia (13.66 x 103/µl; supplementary table 1], serum biochemistry 
(glucose, serum total protein, BUN and creatinine within normal values; supplementary table 2), 
urinalysis [decreased urine density (1.020)] and abdominal ultrasonography (showing uterine 
distension by fluid and a mass in the left ovary). Ovariohysterectomy was recommended for 
suspected pyometra. Recovery from the surgery was uneventful and the dog was discharged 48 
hours after surgery with large spectrum antibiotherapy (amoxicillin and clavulanic acid, 20 mg/kg, 
q12h, 10 days) and non-steroidal anti-inflammatory (meloxicam, 0.1 mg/kg, q24h, five days) 
medication. The post-surgical follow-up appointments were uneventful. Clinical controls, including 
abdominal ultrasonography, were performed at one, three, six, nine and 12 months after surgery. 
The animal was disease-free at the 12-month post-surgery control. 
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The resected genital tract was fixed in 10% buffered formalin and submitted to the histopathological 
evaluation. At inspection, an enlarged and irregularly shaped left ovary (Figure1) was found, with 
8x5x4 cm (length x width x thickness), but the right ovary (2.5x1.5x1.5 cm) was morphologically 
normal. On cross-section, the left ovary presented a uniform, compact mass tissue affecting the 
majority of the parenchyma, which was reduced to a margin with 0.3 mm, and multiple cystic 
structures, the biggest with 3 cm in diameter. The uterus presented an irregular morphology and a 
hemorrhagic content (right horn: 22x2cm; left horn: 30x3.5 cm in length and diameter, respectively). 
Beside the marked dilation, the left uterine horn showed multiple adhesions between its cranial end 
and the ovarian bursa, displacing the ovary to the mesometrial side of the uterine horn.  
Ovarian and uterine sections were routinely processed, paraffin embedded, and stained with 
hematoxylin-eosin (H-E). Immunohistochemistry was performed with specific antibodies against 
neuronal specific enolase (NSE), S-100, vimentin, broad-spectrum cytokeratin (CK) AE1-AE3, CK7, and 
inhibin (Table 1), with 3,3-Diaminobenzidine (DAB) as chromogen and Gill’s Hematoxylin for 
counterstaining.  
Histologically, the parenchyma of the right ovary presented multiple small surface cysts and Call-
Exner-like bodies in the medulla. Atrophy of the left ovary parenchyma was confirmed, the 
compression exerted by a mass composed of a proliferation of well-differentiated nervous tissue 
(Figure2 A to D), surrounded by a dense connective tissue. Neoplastic cells showed strong 
cytoplasmic immunoreactivity against both S-100 and NSE, occasional positivity to vimentin, but 
were negative to tested CKs and inhibin (Figure2 E to H). The surface epithelium showed strong 
immunoreactivity to CK AE1-AE3 and CK7, while the stroma was positive to vimentin and interstitial 
glands positive to inhibin. 
The uterus displayed cystic glandular hyperplasia, with a mucopurulent content in the glands and 
lumen, contaminated with cocci bacteria. In the cranial segment of the left horn, it was observed 
proliferation of the endometrium showing cellular atypia, aberrant cells with evident nucleoli and 
mitosis in a papillary disposition, invading the muscular layer. The neoplastic cells were positive to 
large spectrum keratin and CK7 (Figure 3). 
Supported by the histopathological findings, the diagnosis was mature ovarian monophasic teratoma 
co-existing with an endometrial adenocarcinoma and septic pyometra.  
Ethical approval was not deemed necessary for this study; the informed consent of the owners was 
granted to publicly describe the current case.  
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Discussion 
Ovarian and endometrial tumors are considered rare in dogs, albeit some bias may result from the 
customary practice of spaying in early ages (Saba and Lawrence 2012). Ovarian teratomas are the 
less common type of ovarian neoplasms in female dogs. They are characterized by proliferation of 
any tissue of embryonic origin (e.g. skin, sebaceous glands, hair follicles, adipocytes or nervous 
tissue, among others). In the case described herein, a proliferation of only one type of germinative 
cell (nervous tissue) was observed, and consequently a diagnosis of monophasic mature teratoma 
was established. To the authors’ knowledge, only one other case of was previously reported in dogs, 
in an ovarian remnant of a 5-years-old mixed bred bitch (Rota et al. 2013). 
The morphological appearance of the neoplastic cells in the H-E staining clearly evidenced the neural 
origin of tumor cells, as further confirmed by the positive immunoreactivity against NSE, S-100 and 
vimentin. On the atrophic ovarian parenchyma, positivity to vimentin, CK A1/A3, CK7 and inhibin 
confirmed the presence of typical ovarian components. The negative labelling for keratin and inhibin 
in the neoplastic cells excluded the presence of tissues from other origins in the teratoma and other 
ovarian tumors. 
Adenocarcinomas are considered rare neoplasm in the canine uterus (Maya-Pulgarin et al. 2017), 
contrasting to other domestic species (Kennedy et al. 1998), including the queen (Saraiva et al. 
2015). Dogs tend to develop degenerative and inflammatory conditions of the endometrium (e.g., 
cystic hyperplasia and pyometra) with age and in response to irritative stimuli (Payan-Carreira and 
Pires 2016). 
Clinical signs associated with endometrial adenocarcinomas depend upon the tumor size and the 
presence of metastatic disease or other comorbidities. They are often clinically masked by signs 
common to most genital tract diseases (Payan-Carreira and Pires 2016), such as vaginal discharge. 
Other clinical signs include anorexia and abdominal discomfort or enlargement. Adenocarcinomas 
might be underdiagnosed in dogs due to an inadequate post-surgical or post-mortem evaluation of 
the genital tract. As the clinical signs are often misinterpreted as pyometra or abortion, the 
histopathological evaluation of genital apparatus is seldom required.  
In the present case, the same patient presented two rare tumors: a monophasic teratoma and an 
endometrial adenocarcinoma. This diagnosis was only possible after a careful and detailed 
histopathological evaluation, emphasizing the importance of this exam. Immunohistochemistry 
confirmed the presence of only neuronal tissue on the teratoma and determined the endometrial 
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origin of the uterine lesion, proving the usefulness to differentiate and describe different tumor cell 
populations.  
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Table 1: Antibodies used to characterize the ovarian and endometrial lesions 
Antibody 
Target structure/tissue 
(intensity) 
Clone Supplier Dilution Antigen retrieval Incubation 
NSE - Neuron 
Specific Enolase 
Nerve bundles in the ovary 
(moderate) 
Nervous cells (in teratoma) 
Neuroendocrine cells (weak 
to moderate) 
E27 Ab1 (mouse 
monoclonal 
antibody) 
Thermo Fisher 
Scientific, United 
Kingdom 
1:400 
Citrate, pH 6; 1 cycle 5’ MW 
room temperature, 2 hours  
S-100 
Rete ovarii & stromal cells 
(strong) 
Nervous cells (in teratoma) 
NCL-S100p (rabbit 
polyclonal 
antibody) 
Novocastra, 
United Kingdom 
1:100 4°C, Overnight  
VIMENTIN 
Ovarian stroma (strong)  
Surface epithelium and sub-
surface epithelial structures 
& rete ovarii (irregular) 
Granulosa cells (moderate) 
NCL-L-Vim-V9 
(mouse monoclonal 
antibody) 
Novocastra, 
United Kingdom 
1:50 4°C, Overnight 
CK AE1/AE3 
Surface epithelium, sub-
surface epithelial structures 
(strong) 
rete ovarii (moderate) 
Endometrial epithelium 
Uterine epithelia 
AE1⁄AE3 (mouse 
monoclonal 
antibody) 
Dako® Corp., USA 1:100 4°C, Overnight 
INHIBIN alpha 
Granulosa cells (moderate 
to strong) 
MCA951S (mouse 
monoclonal 
antibody)  
Bio-Rad Serotec, 
USA 
1:25 
Citrate, pH 6; 3 cycles 5’ 
MW 
4°C, Overnight 
CK7 
Surface ovarian epithelium 
(moderate) 
Sub-surface epithelial 
structures (weak) 
Endometrial epithelium 
R17-S (rabbit 
polyclonal 
antibody) 
DB Biotech, 
Slovakia 
1:50 
Citrate, pH 6; 3’ pressure 
cooker 
4°C, Overnight 
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Supplementary Table 1 – Hematology tests results at admission 
Parameter Units Results Reference range 
WBC 10^3/uL 16.14 6.0 – 17.0 
Neutrophils 
10^3/uL 
% 
13.66 
84.6 
3.62 – 12.30 
52.0 – 81.0 
Lymphocytes 
10^3/uL 
% 
1.12 
7.0 
0.83 – 4.91 
12.0 – 33.0 
Monocytes 
10^3/uL 
% 
1.26 
7.8 
0.04 – 1.62 
2.0 – 13.0 
Eosinophils 
10^3/uL 
% 
0.07 
0.5 
0.04 – 1.62 
0.5 – 10.0 
Basophiles 
10^3/uL 
% 
0.03 
0.1 
0.00 – 0.12 
0.0 – 1.3 
RBC 10^6/uL 6.22 5.10 – 8.50 
HBG g/dL 14.4 11.0 – 19.0 
HCT % 42.7 33.0 – 56.0 
MCV fL 68.7 60.0 – 76.0 
MCH pg 32.2 20.0 – 27.0 
MCHC g/dL 33.7 30.0 – 38.0 
PLT 10^3/uL 167 117 - 490 
MPV fL 10.4 8.0 – 14.1 
PDW  17.5 12.0 – 17.5 
PCT % 0.174 0.090 – 0.580 
 
Supplementary Table 2 – Serum biochemistry tests results at admission [Fujifilm Dry-
Chem NX500i] 
Parameter Units Results Reference range 
BUN mg/dL 15.2 9.2 – 29.2 
Creatinin mg/dL 0.6 0.4 – 1.4 
Glucose  mg/dL 112 76–119 
Serum total protein  g/dL 6.4 5.4–7.5 
 
